» Articles » PMID: 34870592

Src Activates Retrograde Membrane Traffic Through Phosphorylation of GBF1

Overview
Journal Elife
Specialty Biology
Date 2021 Dec 6
PMID 34870592
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The Src tyrosine kinase controls cancer-critical protein glycosylation through Golgi to ER relocation of GALNTs enzymes. How Src induces this trafficking event is unknown. Golgi to ER transport depends on the GTP exchange factor (GEF) GBF1 and small GTPase Arf1. Here, we show that Src induces the formation of tubular transport carriers containing GALNTs. The kinase phosphorylates GBF1 on 10 tyrosine residues; two of them, Y876 and Y898, are located near the C-terminus of the Sec7 GEF domain. Their phosphorylation promotes GBF1 binding to the GTPase; molecular modeling suggests partial melting of the Sec7 domain and intramolecular rearrangement. GBF1 mutants defective for these rearrangements prevent binding, carrier formation, and GALNTs relocation, while phosphomimetic GBF1 mutants induce tubules. In sum, Src promotes GALNTs relocation by promoting GBF1 binding to Arf1. Based on residue conservation, similar regulation of GEF-Arf complexes by tyrosine phosphorylation could be a conserved and widespread mechanism.

Citing Articles

Botulinum toxin intoxication requires retrograde transport and membrane translocation at the ER in RenVM neurons.

Yeo J, Tay F, Bennion R, Loss O, Maignel J, Pons L Elife. 2024; 12.

PMID: 39196607 PMC: 11357346. DOI: 10.7554/eLife.92806.


Mechanism, structural and functional insights into nidovirus-induced double-membrane vesicles.

Wang X, Chen Y, Qi C, Li F, Zhang Y, Zhou J Front Immunol. 2024; 15:1340332.

PMID: 38919631 PMC: 11196420. DOI: 10.3389/fimmu.2024.1340332.


Genetics of glycosylation in mammalian development and disease.

Stanley P Nat Rev Genet. 2024; 25(10):715-729.

PMID: 38724711 DOI: 10.1038/s41576-024-00725-x.


-GlcNAc Dynamics: The Sweet Side of Protein Trafficking Regulation in Mammalian Cells.

Ben Ahmed A, Lemaire Q, Scache J, Mariller C, Lefebvre T, Vercoutter-Edouart A Cells. 2023; 12(10).

PMID: 37408229 PMC: 10216988. DOI: 10.3390/cells12101396.


A Sweet Warning: Mucin-Type O-Glycans in Cancer.

Zhang Y, Sun L, Lei C, Li W, Han J, Zhang J Cells. 2022; 11(22).

PMID: 36429094 PMC: 9688771. DOI: 10.3390/cells11223666.


References
1.
Qiao Y, Molina H, Pandey A, Zhang J, Cole P . Chemical rescue of a mutant enzyme in living cells. Science. 2006; 311(5765):1293-7. DOI: 10.1126/science.1122224. View

2.
Donaldson J, Jackson C . ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol. 2011; 12(6):362-75. PMC: 3245550. DOI: 10.1038/nrm3117. View

3.
Kannan S, Poulsen A, Yang H, Ho M, Ang S, Eldwin T . Probing the binding mechanism of Mnk inhibitors by docking and molecular dynamics simulations. Biochemistry. 2014; 54(1):32-46. DOI: 10.1021/bi501261j. View

4.
Gommel D, Memon A, Heiss A, Lottspeich F, Pfannstiel J, Lechner J . Recruitment to Golgi membranes of ADP-ribosylation factor 1 is mediated by the cytoplasmic domain of p23. EMBO J. 2001; 20(23):6751-60. PMC: 125325. DOI: 10.1093/emboj/20.23.6751. View

5.
Nguyen A, Chia J, Ros M, Hui K, Saltel F, Bard F . Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis. Cancer Cell. 2017; 32(5):639-653.e6. DOI: 10.1016/j.ccell.2017.10.001. View